Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs CSX Corporation (CSX) Price & Performance

Amgen, Inc.Trade
CSX CorporationTrade

Price performance (Past 24H)

Key statistics

Amgen, Inc. vs CSX Corporation — how do they compare? Amgen, Inc. trades at $412.21 (market cap $225.71B), while CSX Corporation trades at $50.03 (market cap $92.88B). The key difference: Amgen, Inc. is far larger — about 2.4× CSX Corporation's market cap, and Amgen, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.

AMGNCSX
Market Cap
$225.71B$92.88B
Sector
HealthIndustrials
52-Week High
$417.20$53.21
52-Week Low
$271.18$32.05
Enterprise Value
$269.02B$110.85B
Dividend Yield
2.42%1.12%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About CSX Corporation

Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.

Read more on CSX